Current Neuro-Oncology


Volume 25 Number 5
15 March 2023


Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 5, 15 March






Yağcı-Küpeli B, Pehlivan D.
Bevacizumab-containing regimens for children with relapsed or refractory tumors.
Indian J Cancer. 2022 Jun 29
. doi: 10.4103/ijc.IJC_907_20(?). PMID: 36861699. Observational study. ˍ




Weng G, Ermiş E, Maragkou T, Krcek R, Reinhardt P, Zubak I, Schucht P, Wiest R, Slotboom J, Radojewski P.
Accurate prediction of isocitrate dehydrogenase -mutation status of gliomas using SLOW-editing magnetic resonance spectroscopic imaging at 7 T MR.
Neurooncol Adv. 2023 Jan 3;5(1):vdad001. doi: 10.1093/noajnl/vdad001. PMID: 36875625. Observational study. ˍ




Bosio A, Cerretti G, Padovan M, Caccese M, Denaro L, Chioffi F, Della Puppa A, Aldegheri V, Guarneri V, Zagonel V, Lombardi G.
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study.
Clin Oncol (R Coll Radiol). 2023 Feb 2:S0936-6555(23)00017-1
. doi: 10.1016/j.clon.2023.01.012. PMID: 36858930. Observational study. ˍ




Mou B, Cruz-Lim EM.
Recurrent Extraneural Metastatic Medulloblastoma in an Adult Presenting With a Superscan and Treated With Radium-223.
Cureus. 2023 Feb 7;15(2):e34732. doi: 10.7759/cureus.34732. PMID: 36909024. Case report. ˍ




Uetani H, Azuma M, Khant ZA, Watanabe Y, Kudo K, Kadota Y, Yokogami K, Takeshima H, Kuroda JI, Shinojima N, Hamasaki T, Mukasa A, Hirai T.
Importance of Age and Noncontrast-Enhancing Tumor as Biomarkers for Isocitrate Dehydrogenase-Mutant Glioblastoma: A Multicenter Study.
J Comput Assist Tomogr. 2023 Feb 10. doi: 10.1097/RCT.0000000000001456. PMID: 36877775. Observational study. ˍ




Renovanz M, Kurz SC, Rieger J, Walter B, Becker H, Hille H, Bombach P, Rieger D, Grosse L, Häusser L, Skardelly M, Merk DJ, Paulsen F, Hoffmann E, Gani C, Neumann M, Beschorner R, Rieß O, Roggia C, Schroeder C, Ossowski S, Armeanu-Ebinger S, Gschwind A, Biskup S, Schulze M, Fend F, Singer S, Zender L, Lengerke C, Brucker SY, Engler T, Forschner A, Stenzl A, Kohlbacher O, Nahnsen S, Gabernet G, Fillinger S, Bender B, Ernemann U, Öner Ö, Beha J, Malek HS, Möller Y, Ruhm K, Tatagiba M, Schittenhelm J, Bitzer M, Malek N, Zips D, Tabatabai G.
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system.
Neurooncol Adv. 2023 Feb 14;5(1):vdad012. doi: 10.1093/noajnl/vdad012. PMID: 36915613. Interventional study. ˍ




Bărăian AI, Iacob BC, Sorițău O, Tomuță I, Tefas LR, Barbu-Tudoran L, Șușman S, Bodoki E.
Ruxolitinib-Loaded Imprinted Polymeric Drug Reservoir for the Local Management of Post-Surgical Residual Glioblastoma Cells.
Polymers (Basel). 2023 Feb 15;15(4):965
. doi: 10.3390/polym15040965. PMID: 36850247. Laboratory investigation. ˍ




Goldsmith HS.
Introduction of chemotherapy by omentum for a glioblastoma WHO-IV.
Surg Neurol Int. 2023 Feb 17;14:59. doi: 10.25259/SNI_1080_2022. PMID: 36895220. Editorial. ˍ




Shen F, Li J, Liu F, Sun N, Qiu X, Ding W, Sun X.
The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis.
Front Oncol. 2023 Feb 17;13:1095362. doi: 10.3389/fonc.2023.1095362. PMID: 36874124. Observational study. ˍ




Bigagli E, Agostiniani S, Pugi A, Rombi B, Tornaboni EE, Censullo ML, Gori CG, Pavone R, Sardi I.
Unforeseen cytomegalovirus retinopathy following high dose thiotepa and proton irradiation in a pediatric patient with high-risk medulloblastoma: A case report.
Front Pediatr. 2023 Feb 21;11:1145941. doi: 10.3389/fped.2023.1145941. PMID: 36896395. Case report. ˍ



*

Liu Y, Li L, Hu H, Yang J, Zhang X, Chen L, Chen F, Hao S, Li W, Huang G.
Association between preoperative hematocrit and postoperative 30-day mortality in adult patients with tumor craniotomy.
Front Neurol. 2023 Feb 21;14:1059401. doi: 10.3389/fneur.2023.1059401. PMID: 36895901. Observational study. ˍ




Ladenhauf VK, Galijasevic M, Kerschbaumer J, Freyschlag CF, Nowosielski M, Birkl-Toeglhofer AM, Haybaeck J, Gizewski ER, Mangesius S, Grams AE.
Peritumoral ADC Values Correlate with the MGMT Methylation Status in Patients with Glioblastoma.
Cancers (Basel). 2023 Feb 22;15(5):1384. doi: 10.3390/cancers15051384. PMID: 36900177. Observational study. ˍ




Krishnatry R, Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu A, Gupta T, Jalali R.
Institutional Patterns of Care of Diffuse Intrinsic Pontine Glioma.
Neurol India. 2023 Feb 24;71(1):72-78
. doi: 10.4103/0028-3886.370459(?). PMID: 36861577. Observational study. ˍ




Malhotra KP, Kaif M, Malhotra HS, Husain N.
A Novel Case of Primary Conus Medullaris Epithelioid Glioblastoma with Gliosarcomatous Differentiation.
Neurol India. 2023 Feb 24;71(1):132-134
. doi: 10.4103/0028-3886.370454(?) PMID: 36861587. Case report. ˍ




Sangeeta T, Prerana R, Kumar AA, Amarnath J.
Simultaneous Amino Acid PET/MRI - An Opportunity to Assess True Response in Recurrent High-Grade Glioma after Antiangiogenic Therapy.
Neurol India. 2023 Feb 24;71(1):158-159
. doi: 10.4103/0028-3886.370455(?) PMID: 36861599. Letter to the editor, Case report. ˍ



*

Shahab SW, Schniederjan M, Vega JV, Little S, Reisner A, MacDonald T, Aguilera D.
Case report: ATIC-ALK fusion in infant-type hemispheric glioma and response to lorlatinib.
Front Oncol. 2023 Feb 24;13:1123378. doi: 10.3389/fonc.2023.1123378. PMID: 36910660. Case report. ˍ




Aftahy AK, Butenschoen VM, Hoenikl L, Liesche-Starnecker F, Wiestler B, Schmidt-Graf F, Meyer B, Gempt J.
A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis.
BMC Neurol. 2023 Feb 28;23(1):87
. doi: 10.1186/s12883-023-03135-4. PMID: 36855102. Case report. ˍ




Tringale KR, Wolden SL, Karajannis M, Haque S, Pasquini L, Yildirim O, Rosenblum M, Benhamida JK, Cheung NK, Souweidane M, Basu EM, Pandit-Taskar N, Zanzonico PB, Humm JL, Kramer K.
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
J Neurooncol. 2023 Feb 28. doi: 10.1007/s11060-022-04235-w. PMID: 36853490. Interventional study. ˍ






Królicki L, Kunikowska J, Bruchertseifer F, Kuliński R, Pawlak D, Koziara H, Rola R, Morgenstern A, Merlo A.
Locoregional Treatment of Glioblastoma With Targeted α Therapy: [213Bi]Bi-DOTA-Substance P Versus [225Ac]Ac-DOTA-Substance P-Analysis of Influence Parameters.
Clin Nucl Med. 2023 Mar 1
. doi: 10.1097/RLU.0000000000004608. PMID: 36854309. Observational study˰ ˍ




Bergengruen PM, Hernaíz Driever P, Budach V, Zips D, Grün A.
Second course of re-irradiation in pediatric diffuse intrinsic pontine glioma : A case study.
Strahlenther Onkol. 2023 Mar 2
. doi: 10.1007/s00066-023-02057-x. PMID: 36862153. Case report. ˍ




Kaisman-Elbaz T, Xiao T, Grabowski MM, Barnett GH, Mohammadi AM.
The Impact of Extent of Ablation on Survival of Patients With Newly Diagnosed Glioblastoma Treated With Laser Interstitial Thermal Therapy: A Large Single-Institutional Cohort.
Neurosurgery. 2023 Mar 2
. doi: 10.1227/neu.0000000000002430. PMID: 36861990. Observational study˰ ˍ




Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ, Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM, Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow JE, Kizilbash SH, Tortorelli S, Burns TC.
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas.
medRxiv [Preprint]. 2023 Mar 2:2023.03.01.23286412. doi: 10.1101/2023.03.01.23286412. PMID: 36909488. Laboratory investigation. ˍ




Said MM, Broen MPG, Swart EL, Bartelink IH, Kouwenhoven MCM.
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
Cancers (Basel). 2023 Mar 2;15(5):1561. doi: 10.3390/cancers15051561. PMID: 36900352. Editorial. ˍ




Azad TD, Kalluri AL, Hansen LJ, Ammar A, Cohen AR.
H3 K27-altered diffuse midline glioma presenting as massive cerebellopontine hemorrhage.
Childs Nerv Syst. 2023 Mar 3
. doi: 10.1007/s00381-023-05904-5. PMID: 36867241. Case report˰ ˍ




Gong M, Fan X, Yu H, Niu W, Sun S, Wang H, Chen X.
Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
Mol Neurobiol. 2023 Mar 3
. doi: 10.1007/s12035-023-03288-w. PMID: 36867344. Laboratory investigation˰ ˍ




Schmidt S, Kovacs E, Usta D, Behnisch R, Sahm F, Haux D, Witt O, Milde T, Unterberg A, El Damaty A.
Cerebellar mutism syndrome following posterior fossa tumor surgery in children - a retrospective single center study.
World Neurosurg. 2023 Mar 3:S1878-8750(23)00268-1
. doi: 10.1016/j.wneu.2023.02.117. PMID: 36871657. Observational study˰ ˍ




Yao J, Li S, Cui Q, Ren Y, Li M, Wang J, Zeng M, Ji N, Peng Y, Sessler DI.
Intraoperative hypotension and postoperative stroke in older patients who had brain tumour resections: a retrospective cohort analysis.
World Neurosurg. 2023 Mar 4:S1878-8750(23)00284-X. doi: 10.1016/j.wneu.2023.02.136. PMID: 36878404. Observational study˰ ˍ




Łach K, Kowal A, Perek-Polnik M, Jakubczyk P, Arthur CJ, Bal W, Drogosiewicz M, Dembowska-Bagińska B, Grajkowska W, Cebulski J, Chaber R.
Infrared Spectroscopy as a Potential Diagnostic Tool for Medulloblastoma.
Molecules. 2023 Mar 5;28(5):2390. doi: 10.3390/molecules28052390. PMID: 36903631. Observational study. ˍ




Henriksen KA, Von Oettingen G, Skjøth-Rasmussen J, Mathiasen R, Foss-Skiftesvik J.
Assessment of the Milan Complexity Scale for prediction of postoperative morbidity in pediatric neuro-oncological surgery.
Childs Nerv Syst. 2023 Mar 6. doi: 10.1007/s00381-023-05902-7. PMID: 36877208. Observational study˰ ˍ




Jatana S, Mohammad AH, Al-Saadi TD, Carias M, Guevara-Moriones N, Ruiz-Barrera MA, Mindru CS, Diaz RJ.
Characterization of perioperative glycemic status and dexamethasone use with associated postoperative complications in glioblastoma patients.
Acta Neurochir (Wien). 2023 Mar 6. doi: 10.1007/s00701-023-05541-6. PMID: 36879101. Observational study˰ ˍ




More S, Naiker T, Jacobs N, Oompie F, Prasad V.
Short-Interval, Low-Dose [177Lu]Lu-Prostate-Specific Membrane Antigen in the Treatment of Refractory Glioblastoma.
Clin Nucl Med. 2023 Mar 6. doi: 10.1097/RLU.0000000000004612. PMID: 36881610. Case report˰ ˍ




Trifiletti DM, Akinyelu T, Burri SH, Jeudy A, Quinones-Hinojosa A, Prabhu RS.
Glioma inadvertently treated with preoperative stereotactic radiosurgery: focusing on safety.
J Neurooncol. 2023 Mar 6. doi: 10.1007/s11060-023-04278-7. PMID: 36877383. Case report˰ ˍ




Ajuyah P, Mayoh C, Lau LMS, Barahona P, Wong M, Chambers H, Valdes-Mora F, Senapati A, Gifford AJ, D'Arcy C, Hansford JR, Manoharan N, Nicholls W, Williams MM, Wood PJ, Cowley MJ, Tyrrell V, Haber M, Ekert PG, Ziegler DS, Khuong-Quang DA.
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.
Sci Rep. 2023 Mar 7;13(1):3775. doi: 10.1038/s41598-023-30395-4. PMID: 36882456. Case report, Interventional study. ˍ




Friker LL, Tzaridis T, Enkirch SJ, Lüders C, Hattingen E, Kristiansen G, Goschzik T, Waha A, Lütter C, Weller J, Herrlinger U, Pietsch T, Gessi M, Baumert BG, Gielen GH.
Gliosarcoma with extensive extracranial metastatic spread and familial coincidence: A case report.
Pathol Res Pract. 2023 Mar 7;244:154399. doi: 10.1016/j.prp.2023.154399. PMID: 36905695. Case report˰ ˍ




Kaneoka A, Fujimoto SH, Tamura K, Inaji M, Maehara T.
Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study.
Discov Oncol. 2023 Mar 7;14(1):30. doi: 10.1007/s12672-023-00632-3. PMID: 36881187. Observational study. ˍ




Pace A, Belleudi V, Tanzilli A, Villani V, Poggi FR, Benincasa D, Davoli M, Pinnarelli L.
Pattern of care of brain tumor patients in the last months of life: analysis of a cohort of 3045 patients in the last 10 years.
Neurol Sci. 2023 Mar 7. doi: 10.1007/s10072-023-06722-y. PMID: 36882595. Observational study˰ ˍ




Kang Z, Li S, Lin Y, Li Y, Mao Y, Zhang J, Lei T, Wang H, Su Y, Yang Y, Qiu J, Li W.
A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors.
Invest New Drugs. 2023 Mar 8. doi: 10.1007/s10637-022-01325-4. PMID: 36884148. Interventional study. ˍ




Champeaux-Depond C, Jecko V, Weller J, Constantinou P, Tuppin P, Metellus P.
Newly-diagnosed high grade glioma surgery with carmustine wafers implantation. A long-term nationwide retrospective study.
World Neurosurg. 2023 Mar 10:S1878-8750(23)00311-X. doi: 10.1016/j.wneu.2023.03.015. PMID: 36906091. Observational study˰ ˍ




Fuentes-Fayos AC, G-García ME, Pérez-Gómez JM, Montero-Hidalgo AJ, Martín-Colom J, Doval-Rosa C, Blanco-Acevedo C, Torres E, Toledano-Delgado Á, Sánchez-Sánchez R, Peralbo-Santaella E, Ortega-Salas RM, Jiménez-Vacas JM, Tena-Sempere M, López M, Castaño JP, Gahete MD, Solivera J, Luque RM.
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
EBioMedicine. 2023 Mar 10;90:104484. doi: 10.1016/j.ebiom.2023.104484. PMID: 36907105. Laboratory investigation, Observational study. ˍ




Shiba Y, Motomura K, Taniguchi R, Kurimoto M, Mizutani K, Ohka F, Aoki K, Ito E, Nishikawa T, Yamaguchi J, Kibe Y, Shimizu H, Maeda S, Nakashima T, Suzuki H, Muramatsu H, Takahashi Y, Saito R.
Efficacy and safety of bevacizumab, irinotecan, and temozolomide combination for relapsed or refractory pediatric central nervous system embryonal tumor: a single-institution study.
J Neurosurg Pediatr. 2023 Mar 10:1-9. doi: 10.3171/2023.1.PEDS22345. PMID: 36905668. Observational study˰ ˍ



*

Hou Z, Wu H, Luo N, Li S, Zhang X, Dong S, Zhu D, Zhang H, Tao R.
Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation.
Oncologist. 2023 Mar 13:oyac280. doi: 10.1093/oncolo/oyac280. PMID: 36913260. Case report. ˍ




Sharma M, McKenzie GW, Gaskins J, Yusuf M, Woo S, Mistry AM, Williams BJ.
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis.
J Neurooncol. 2023 Mar 13. doi: 10.1007/s11060-023-04286-7? PMID: 36913046. Observational study˰ ˍ




Pearl H, Fleischer CC.
Association between altered metabolism and genetic mutations in human glioma.
Cancer Rep (Hoboken). 2023 Mar 14:e1799. doi: 10.1002/cnr2.1799. PMID: 36916606. Laboratory investigation. ˍ




Wu HW, Wu CH, Lin SC, Wu CC, Chen HH, Chen YW, Lee YY, Chang FC.
MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
Cancer Med. 2023 Mar 14. doi: 10.1002/cam4.5780. PMID: 36916326. Observational study. ˍ